EUVIMEDAtklāt EUVIMED
Open access

Left Atrial Strain as an Early Marker of Anthracycline‐Related Cardiac Dysfunction (LAS‐MACD)

Chonthicha Tanking, Nanthasit Samansit, Chanwit Wuttichaipradit

Echocardiography · 2026

DOI: 10.1111/echo.70629 ↗

At a glance

Journal article in Echocardiography, 2026. Written by Chonthicha Tanking and 2 co-authors. Institution: Department of Cardiology, Chulabhorn Hospital, Bangkok, Thailand. Major MEDLINE topics: Anthracyclines, Echocardiography, Breast Neoplasms, Heart Atria. 16 references. The full text is freely available in PubMed Central.

AbstraktsSubjectsBibliogrāfiskie datiCiteRelated studies

Abstract (original language)

Purpose

Global longitudinal strain (GLS) is the recommended marker for cancer therapy–related cardiac dysfunction (CTRCD) but may miss the earliest myocardial changes. We examined whether early decline in left atrial strain (LAS) precedes GLS change in patients who subsequently develop CTRCD.

Methods

In a single‐center retrospective cohort of 62 women with breast cancer, speckle‐tracking echocardiography measured LAS and GLS at baseline (T0), after the fourth anthracycline cycle (T1), and 3–6 months after treatment (T2). CTRCD (2022 ESC criteria) was classified by onset (T1 or T2). Analyses were exploratory.

Results

CTRCD occurred in 26 patients (41.9%): 8 T1‐onset, 18 T2‐onset. In T2‐onset patients, the early (T0→T1) relative decline in LA reservoir strain (LASr) already exceeded that of no‐CTRCD patients (−19.5 ± 13.9% vs −6.4 ± 11.3%; p = 0.001), whereas early GLS change did not differ ( p = 0.43). Early LASr change had the highest area under the curve (AUC) for subsequent CTRCD (0.78; 95% CI 0.65–0.90) versus GLS (0.59; DeLong p = 0.10). An exploratory 6.35% LASr decline threshold gave 100% sensitivity (95% CI 82–100%), 56% specificity (95% CI 40–71%), and 100% negative predictive value; bootstrap‐corrected AUC was 0.77. LASr and GLS were only weakly‐to‐moderately correlated (r = −0.29 baseline; r = −0.41 early change).

Conclusion

In this small retrospective cohort, early LASr decline was associated with, and tended to precede, GLS change in women who subsequently developed anthracycline‐associated CTRCD. These hypothesis‐generating findings support LASr as a potential early, high‐sensitivity adjunctive marker requiring prospective validation.

Subjects

MeSH terms (MEDLINE)

AnthracyclinesEchocardiographyBreast NeoplasmsHeart AtriaHeart DiseasesHumansFemaleRetrospective StudiesGlobal Longitudinal StrainMiddle AgedCardiotoxicity

Author keywords

cancer therapy–related cardiac dysfunctioncardio‐oncologyglobal longitudinal strainleft atrial strainspeckle‐tracking echocardiography

Substances

Anthracyclines

Authors and institutions

  • Department of Cardiology, Chulabhorn Hospital, Bangkok, Thailand.

Cite

APA

Tanking, C., Samansit, N., & Wuttichaipradit, C. (2026). Left Atrial Strain as an Early Marker of Anthracycline‐Related Cardiac Dysfunction (LAS‐MACD). Echocardiography. https://doi.org/10.1111/echo.70629

Vancouver

Tanking C, Samansit N, Wuttichaipradit C. Left Atrial Strain as an Early Marker of Anthracycline‐Related Cardiac Dysfunction (LAS‐MACD). Echocardiography. 2026. doi:10.1111/echo.70629

BibTeX
@article{Tanking2026,
  author = {Tanking, Chonthicha and Samansit, Nanthasit and Wuttichaipradit, Chanwit},
  title = {Left Atrial Strain as an Early Marker of Anthracycline‐Related Cardiac Dysfunction (LAS‐MACD)},
  journal = {Echocardiography},
  year = {2026},
  doi = {10.1111/echo.70629}
}
Start for free →